Visual signs and symptoms of Parkinson's disease

Parkinson's disease (PD) is a common disorder of middle‐aged and elderly people, in which there is degeneration of the extra‐pyramidal motor system. In some patients, the disease is associated with a range of visual signs and symptoms, including defects in visual acuity, colour vision, the blink reflex, pupil reactivity, saccadic and smooth pursuit movements and visual evoked potentials. In addition, there may be psychophysical changes, disturbances of complex visual functions such as visuospatial orientation and facial recognition, and chronic visual hallucinations. Some of the treatments associated with PD may have adverse ocular reactions. If visual problems are present, they can have an important effect on overall motor function, and quality of life of patients can be improved by accurate diagnosis and correction of such defects. Moreover, visual testing is useful in separating PD from other movement disorders with visual symptoms, such as dementia with Lewy bodies (DLB), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Although not central to PD, visual signs and symptoms can be an important though obscure aspect of the disease and should not be overlooked.

[1]  C. Evinger,et al.  Aging of the trigeminal blink system , 2001, Experimental Brain Research.

[2]  T. Paolo,et al.  The retinal dopamine system in Parkinson's disease , 1993 .

[3]  J. Jankovic,et al.  Neuro-ophthalmic findings in progressive supranuclear palsy. , 1992, Journal of clinical neuro-ophthalmology.

[4]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[5]  W. Kuhn,et al.  Effects of apomorphine on visual functions in Parkinson's disease , 2000, Journal of Neural Transmission.

[6]  M. B. Bender,et al.  Oculomotor function in patients with Parkinson's disease. , 1972, Journal of the neurological sciences.

[7]  W. J. Graham,et al.  Dequalinium in Myasthenia Gravis , 1959, British medical journal.

[8]  P. Nunn,et al.  Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. , 1987, Science.

[9]  H. Przuntek,et al.  Loss of visual acuity under dopamine substitution therapy , 2000 .

[10]  W. Sippell,et al.  Long-Term Follow-Up of Spontaneous Development in a Boy with Familial Male Precocious Puberty , 2004, Hormone Research in Paediatrics.

[11]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[12]  M. Yahr,et al.  Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. , 1987, Brain : a journal of neurology.

[13]  K. Mewes,et al.  Visual fields in patients with posterior GPi pallidotomy , 1998, Neurology.

[14]  Jennifer J. Pokorny,et al.  Activity of substantia nigra pars reticulata neurons during smooth pursuit eye movements in monkeys , 2005, The European journal of neuroscience.

[15]  A. Lang,et al.  Interface between tauopathies and synucleinopathies: A tale of two proteins , 2006, Annals of neurology.

[16]  Nigel J. Cairns,et al.  Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.

[17]  J. Friedman Ophthalmologic features of Parkinson's disease. , 2004, Neurology.

[18]  A. Cronin-Golomb,et al.  Visual and spatial symptoms in Parkinson’s disease , 2005, Vision Research.

[19]  M. Hankins,et al.  Neurobiology of retinal dopamine in relation to degenerative states of the tissue , 1997, Vision Research.

[20]  Andreas U Bayer,et al.  Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. , 2002, American journal of ophthalmology.

[21]  M. Yahr,et al.  Measurements of visual evoked potentials in Parkinson's disease. , 1978, Brain : a journal of neurology.

[22]  R. Carpenter,et al.  Saccadic latency distributions in Parkinson’s disease and the effects of l-dopa , 2006, Experimental Brain Research.

[23]  F. Lepore Parkinson's Disease and Diplopia , 2006 .

[24]  P. Fitzgerald,et al.  Self-paced saccades and saccades to oddball targets in Parkinson's disease , 2006, Brain Research.

[25]  I. Gottlob,et al.  Alteration of visual evoked potentials and electroretinograms in Parkinson's disease. , 1987, Electroencephalography and clinical neurophysiology.

[26]  George W. Bruyn,et al.  Brain's diseases of the nervous system , 1969 .

[27]  E. Neumann,et al.  Benzhexol-induced blindness in Parkinson's disease. , 1972, British medical journal.

[28]  G. Stebbins,et al.  Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model , 2005, Movement disorders : official journal of the Movement Disorder Society.

[29]  A. Laties,et al.  Dopaminergic neurons in the human retina , 1982, The Journal of comparative neurology.

[30]  Peter J. Lang,et al.  A Bio‐Informational Theory of Emotional Imagery , 1979 .

[31]  T. Mauger,et al.  Cholinergic sensitivity of irides from donors with various pathological conditions and lens implants , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[32]  G. Trick,et al.  Visual Impairment in Parkinson's Disease: Deficits in Orientation and Motion Discrimination , 1994, Optometry and vision science : official publication of the American Academy of Optometry.

[33]  T. Horiuchi,et al.  Desmoplastic fibroma of the calvarium , 1998, Journal of clinical neuroscience.

[34]  R. Armstrong,et al.  Alzheimer's disease and the eye , 1996, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[35]  R A Crowther,et al.  Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. , 1998, Neuroscience letters.

[36]  Eye movements in Parkinson's disease: before and after pallidotomy. , 2000, Investigative ophthalmology & visual science.

[37]  P. Silburn,et al.  Prevalence of Parkinson’s disease in metropolitan and rural Queensland: A general practice survey , 2006, Journal of Clinical Neuroscience.

[38]  G. Bernardi,et al.  Visual alterations in de novo Parkinson's disease , 1995, Neurology.

[39]  K. Heilman,et al.  Emotional facial imagery, perception, and expression in Parkinson's disease , 1995, Neurology.

[40]  J. Elias,et al.  Levodopa improves spatial contrast sensitivity in Parkinson's disease. , 1993, Archives of neurology.

[41]  Fractionation of visuoperceptual dysfunction in Parkinson's disease , 1995, Journal of the Neurological Sciences.

[42]  M. Repka,et al.  Ocular motility in Parkinson's disease. , 1996, Journal of pediatric ophthalmology and strabismus.

[43]  G R Barnes,et al.  Progressive bradykinesia and hypokinesia of ocular pursuit in Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[44]  Richard D. Jones,et al.  Impairment of high‐contrast visual acuity in Parkinson's disease , 1992, Movement disorders : official journal of the Movement Disorder Society.

[45]  A. H. Kadish,et al.  Vision loss associated with amantadine hydrochloride use. , 1977, JAMA.

[46]  L. Hunt,et al.  Review of the visual system in Parkinson's disease. , 1995, Optometry and vision science : official publication of the American Academy of Optometry.

[47]  C. Bulens,et al.  Effect of levodopa treatment on contrast sensitivity in Parkinson's disease , 1987, Annals of Neurology.

[48]  L. Henderson,et al.  Predictive responses in Parkinson's disease: manual keypresses and saccadic eye movements to regular stimulus events. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[49]  L. Murri,et al.  Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson’s disease , 2006, Neurological Sciences.

[50]  Colour discrimination impairment is not a reliable early marker of Parkinson's disease , 2001, Journal of Neurology.

[51]  G. Nappi,et al.  Disordered pupil reactivity in Parkinson's disease , 1991, Clinical Autonomic Research.

[52]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[53]  William J. Jagust,et al.  Cortical glucose metabolism in Parkinson's disease without dementia , 1994, Neurobiology of Aging.

[54]  P. Jurák,et al.  The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients. , 2003, Parkinsonism & related disorders.

[55]  C. Figarella,et al.  Developmental Gene Expression and Immunohistochemical Study of the Human Endocrine Pancreas during Fetal Life , 1998, Hormone Research in Paediatrics.

[56]  R. Leigh,et al.  Whipple’s disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording , 1999, Journal of neurology, neurosurgery, and psychiatry.

[57]  W. Weiner,et al.  Visuospatial impairment in Parkinson's disease , 1991, Neurology.

[58]  H. Osmond-Clarke Colles's Fracture , 1951 .

[59]  N. Quinn,et al.  Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations , 2001, Neurology.

[60]  R. Armstrong,et al.  Parkinson's disease and the eye. , 1997, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[61]  H. Shibasaki,et al.  Oculomotor abnormalities in Parkinson's disease. , 1979, Archives of neurology.

[62]  S. Leurgans,et al.  Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. , 2002, Archives of neurology.

[63]  H. Przuntek,et al.  Disturbance of colour perception in Parkinson's disease , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[64]  O. Blin,et al.  Dopaminergic modulation of visual sensitivity in man , 1993, Fundamental & clinical pharmacology.

[65]  N. Accornero,et al.  Color VEPs in Parkinson's disease. , 1994, Electroencephalography and clinical neurophysiology.

[66]  Christian Haass,et al.  Pathological properties of the Parkinson’s disease-associated protein DJ-1 in α-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick’s disease , 2004, Acta Neuropathologica.

[67]  Akiko Tamura,et al.  Impaired Visual Acuity as a Risk Factor for Visual Hallucinations in Parkinson’s Disease , 2006, Journal of geriatric psychiatry and neurology.

[68]  J. S. Liu,et al.  The validity of eye blink rate in Chinese adults for the diagnosis of Parkinson's disease , 2003, Clinical Neurology and Neurosurgery.

[69]  L. Illis,et al.  BRAIN'S DISEASES OF THE NERVOUS SYSTEM , 2002, Spinal Cord.

[70]  R. Feldman,et al.  Abnormalities in color vision and contrast sensitivity in Parkinson's disease , 1992, Neurology.